Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik K Flemington

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Cancer Letters|October 15, 2010
miRNAs in the pathogenesis of oncogenic human virusesZhen Lin, Erik K Flemington
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Use of gene overexpression to assess function in cell cycle controlErik K Flemington, Antonio Rodriguez
Virology|December 14, 2005
siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cellsQinyan Yin, Erik K Flemington
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 20, 2017
A computational framework for distinguishing direct versus indirect interactions in human functional protein-protein interaction networksSuyu Mei, Erik K Flemington, Kun Zhang
Bioinformatics (Oxford, England)|June 29, 2018
Driver gene mutations based clustering of tumors: methods and applicationsWensheng Zhang, Erik K Flemington, Kun Zhang
Virology|August 26, 2004
The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivationQinyan Yin, Kendra Jupiter, Erik K Flemington
BMC Genomics|June 30, 2018
Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: a case study on M. tuberculosisSuyu Mei, Erik K Flemington, Kun Zhang
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
Analysis of EBV Transcription Using High-Throughput RNA SequencingTina O'Grady, Melody Baddoo, Erik K Flemington
Cancer Genetics|October 19, 2016
Mutant TP53 disrupts age-related accumulation patterns of somatic mutations in multiple cancer typesWensheng Zhang, Erik K Flemington, Kun Zhang
Mbio|October 30, 2014
Expanding the conversation on high-throughput virome sequencing standards to include consideration of microbial contamination sourcesMichael J Strong, Zhen Lin, Erik K Flemington
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Cancer Letters|October 15, 2010
miRNAs in the pathogenesis of oncogenic human virusesZhen Lin, Erik K Flemington
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Use of gene overexpression to assess function in cell cycle controlErik K Flemington, Antonio Rodriguez
Virology|December 14, 2005
siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cellsQinyan Yin, Erik K Flemington
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 20, 2017
A computational framework for distinguishing direct versus indirect interactions in human functional protein-protein interaction networksSuyu Mei, Erik K Flemington, Kun Zhang
Bioinformatics (Oxford, England)|June 29, 2018
Driver gene mutations based clustering of tumors: methods and applicationsWensheng Zhang, Erik K Flemington, Kun Zhang
Virology|August 26, 2004
The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-beta1 mediated reactivationQinyan Yin, Kendra Jupiter, Erik K Flemington
BMC Genomics|June 30, 2018
Transferring knowledge of bacterial protein interaction networks to predict pathogen targeted human genes and immune signaling pathways: a case study on M. tuberculosisSuyu Mei, Erik K Flemington, Kun Zhang
Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
Analysis of EBV Transcription Using High-Throughput RNA SequencingTina O'Grady, Melody Baddoo, Erik K Flemington
Cancer Genetics|October 19, 2016
Mutant TP53 disrupts age-related accumulation patterns of somatic mutations in multiple cancer typesWensheng Zhang, Erik K Flemington, Kun Zhang
Mbio|October 30, 2014
Expanding the conversation on high-throughput virome sequencing standards to include consideration of microbial contamination sourcesMichael J Strong, Zhen Lin, Erik K Flemington
Pageof 12